APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Belladonna Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Belladonna Tablets Market Outlook and Growth Opportunities 2026

Report ID 173969630429 December 2025215 pages

Choose your research edition.

Industry ResearchBelladonna Tablets Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Belladonna Tablets Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Belladonna Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Belladonna Tablets Market Outlook and Growth Opportunities 2026215 pages · $4,250 USDMarket Analysis & ForecastGlobal Belladonna Tablets Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Belladonna Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Belladonna Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Belladonna Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Belladonna Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Belladonna Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Belladonna Tablets market include Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd., Yangzhou Aidi Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., Wanbangde Pharmaceutical Group Co., Ltd., CSPC Ouyi Pharmaceutical Co., Ltd., Shenyang Tonglian Pharmaceutical Co., Ltd., Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd., Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. and Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Belladonna Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Belladonna Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Belladonna Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Belladonna Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Belladonna Tablets Segment by Company

Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.

Yangzhou Aidi Pharmaceutical Co., Ltd.

Southwest Pharmaceutical Co., Ltd.

Wanbangde Pharmaceutical Group Co., Ltd.

CSPC Ouyi Pharmaceutical Co., Ltd.

Shenyang Tonglian Pharmaceutical Co., Ltd.

Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.

Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.

Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.

Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.

Jilin Luwang Pharmaceutical Co., Ltd.

Jilin Hengjin Pharmaceutical Co., Ltd.

Jilin Daojun Pharmaceutical Co., Ltd.

Henan Baiquan Pharmaceutical Co., Ltd.

Sinopharm Xinjiang Pharmaceutical Co., Ltd.

Guangxi Dahaiguang Pharmaceutical Co., Ltd.

Gansu Lanyao Pharmaceutical Co., Ltd.

Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.

Aimin Pharmaceutical Group Co., Ltd.

Weleda

Raritan Pharmaceuticals

Hyland's Inc

Belladonna Tablets Segment by Type

Compound Preparations

Single Preparations

Belladonna Tablets Segment by Application

Hospital

Clinic

Other

Belladonna Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Belladonna Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Belladonna Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Belladonna Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Belladonna Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Belladonna Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Belladonna Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Belladonna Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Belladonna Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Belladonna Tablets industry.

Chapter 3: Detailed analysis of Belladonna Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Belladonna Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Belladonna Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Belladonna Tablets Industry Trends Table 2. Belladonna Tablets Industry Drivers Table 3. Belladonna Tablets Industry Opportunities and Challenges Table 4. Belladonna Tablets Industry Restraints Table 5. Global Belladonna Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Belladonna Tablets Revenue Share by Company (2021-2026) Table 7. Global Belladonna Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Belladonna Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Belladonna Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Belladonna Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Belladonna Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Belladonna Tablets Company, Product Type & Application Table 13. Global Belladonna Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Belladonna Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Compound Preparations Table 18. Significant Companies of Single Preparations Table 19. Global Belladonna Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Belladonna Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Belladonna Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Belladonna Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Belladonna Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Belladonna Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Belladonna Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Belladonna Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Belladonna Tablets Sales Value Share by Type (2021-2026) Table 28. Global Belladonna Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Belladonna Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Belladonna Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Belladonna Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Belladonna Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Belladonna Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Belladonna Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Belladonna Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Belladonna Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Belladonna Tablets Sales Value Share by Application (2021-2026) Table 41. Global Belladonna Tablets Sales Value Share by Application (2027-2032) Table 42. Global Belladonna Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Belladonna Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Belladonna Tablets Sales Market Share by Region (2021-2026) Table 45. Global Belladonna Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Belladonna Tablets Sales Market Share by Region (2027-2032) Table 47. Global Belladonna Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Belladonna Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Belladonna Tablets Sales Value Share by Region (2021-2026) Table 50. Global Belladonna Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Belladonna Tablets Sales Value Share by Region (2027-2032) Table 52. Global Belladonna Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Belladonna Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Belladonna Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Belladonna Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Belladonna Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Belladonna Tablets Sales Market Share by Country (2021-2026) Table 58. Global Belladonna Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Belladonna Tablets Sales Market Share by Country (2027-2032) Table 60. Global Belladonna Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Belladonna Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Belladonna Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Belladonna Tablets Sales Value Market Share by Country (2027-2032) Table 64. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Company Information Table 65. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Business Overview Table 66. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Product Portfolio Table 68. Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Recent Development Table 69. Yangzhou Aidi Pharmaceutical Co., Ltd. Company Information Table 70. Yangzhou Aidi Pharmaceutical Co., Ltd. Business Overview Table 71. Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 73. Yangzhou Aidi Pharmaceutical Co., Ltd. Recent Development Table 74. Southwest Pharmaceutical Co., Ltd. Company Information Table 75. Southwest Pharmaceutical Co., Ltd. Business Overview Table 76. Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 78. Southwest Pharmaceutical Co., Ltd. Recent Development Table 79. Wanbangde Pharmaceutical Group Co., Ltd. Company Information Table 80. Wanbangde Pharmaceutical Group Co., Ltd. Business Overview Table 81. Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio Table 83. Wanbangde Pharmaceutical Group Co., Ltd. Recent Development Table 84. CSPC Ouyi Pharmaceutical Co., Ltd. Company Information Table 85. CSPC Ouyi Pharmaceutical Co., Ltd. Business Overview Table 86. CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 88. CSPC Ouyi Pharmaceutical Co., Ltd. Recent Development Table 89. Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information Table 90. Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview Table 91. Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 93. Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Development Table 94. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Company Information Table 95. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Business Overview Table 96. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 98. Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Recent Development Table 99. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Company Information Table 100. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Business Overview Table 101. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 103. Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Recent Development Table 104. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Company Information Table 105. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Business Overview Table 106. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 108. Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Recent Development Table 109. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Company Information Table 110. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Business Overview Table 111. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Product Portfolio Table 113. Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Recent Development Table 114. Jilin Luwang Pharmaceutical Co., Ltd. Company Information Table 115. Jilin Luwang Pharmaceutical Co., Ltd. Business Overview Table 116. Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 118. Jilin Luwang Pharmaceutical Co., Ltd. Recent Development Table 119. Jilin Hengjin Pharmaceutical Co., Ltd. Company Information Table 120. Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview Table 121. Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 123. Jilin Hengjin Pharmaceutical Co., Ltd. Recent Development Table 124. Jilin Daojun Pharmaceutical Co., Ltd. Company Information Table 125. Jilin Daojun Pharmaceutical Co., Ltd. Business Overview Table 126. Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 128. Jilin Daojun Pharmaceutical Co., Ltd. Recent Development Table 129. Henan Baiquan Pharmaceutical Co., Ltd. Company Information Table 130. Henan Baiquan Pharmaceutical Co., Ltd. Business Overview Table 131. Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 133. Henan Baiquan Pharmaceutical Co., Ltd. Recent Development Table 134. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Company Information Table 135. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Business Overview Table 136. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 138. Sinopharm Xinjiang Pharmaceutical Co., Ltd. Recent Development Table 139. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Company Information Table 140. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Business Overview Table 141. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 143. Guangxi Dahaiguang Pharmaceutical Co., Ltd. Recent Development Table 144. Gansu Lanyao Pharmaceutical Co., Ltd. Company Information Table 145. Gansu Lanyao Pharmaceutical Co., Ltd. Business Overview Table 146. Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 148. Gansu Lanyao Pharmaceutical Co., Ltd. Recent Development Table 149. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Company Information Table 150. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Business Overview Table 151. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio Table 153. Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Recent Development Table 154. Aimin Pharmaceutical Group Co., Ltd. Company Information Table 155. Aimin Pharmaceutical Group Co., Ltd. Business Overview Table 156. Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio Table 158. Aimin Pharmaceutical Group Co., Ltd. Recent Development Table 159. Weleda Company Information Table 160. Weleda Business Overview Table 161. Weleda Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Weleda Belladonna Tablets Product Portfolio Table 163. Weleda Recent Development Table 164. Raritan Pharmaceuticals Company Information Table 165. Raritan Pharmaceuticals Business Overview Table 166. Raritan Pharmaceuticals Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. Raritan Pharmaceuticals Belladonna Tablets Product Portfolio Table 168. Raritan Pharmaceuticals Recent Development Table 169. Hyland's Inc Company Information Table 170. Hyland's Inc Business Overview Table 171. Hyland's Inc Belladonna Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 172. Hyland's Inc Belladonna Tablets Product Portfolio Table 173. Hyland's Inc Recent Development Table 174. Key Raw Materials Table 175. Raw Materials Key Suppliers Table 176. Belladonna Tablets Distributors List Table 177. Belladonna Tablets Customers List Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources Table 181. Primary Sources List of Figures Figure 1. Belladonna Tablets Product Image Figure 2. Global Belladonna Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Belladonna Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Belladonna Tablets Sales (2021-2032) & (K Units) Figure 5. Global Belladonna Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Belladonna Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Compound Preparations Image Figure 10. Single Preparations Image Figure 11. Global Belladonna Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Belladonna Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Belladonna Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Belladonna Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Belladonna Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Belladonna Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Belladonna Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Belladonna Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Belladonna Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Belladonna Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Belladonna Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Belladonna Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Belladonna Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Belladonna Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Belladonna Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Belladonna Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Belladonna Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Belladonna Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Belladonna Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Belladonna Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Belladonna Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Belladonna Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Belladonna Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Belladonna Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Belladonna Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Belladonna Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Belladonna Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Belladonna Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Belladonna Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Belladonna Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Belladonna Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Compound Preparations
  • Single Preparations
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.
  • Yangzhou Aidi Pharmaceutical Co., Ltd.
  • Southwest Pharmaceutical Co., Ltd.
  • Wanbangde Pharmaceutical Group Co., Ltd.
  • CSPC Ouyi Pharmaceutical Co., Ltd.
  • Shenyang Tonglian Pharmaceutical Co., Ltd.
  • Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.
  • Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
  • Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
  • Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.
  • Jilin Luwang Pharmaceutical Co., Ltd.
  • Jilin Hengjin Pharmaceutical Co., Ltd.
  • Jilin Daojun Pharmaceutical Co., Ltd.
  • Henan Baiquan Pharmaceutical Co., Ltd.
  • Sinopharm Xinjiang Pharmaceutical Co., Ltd.
  • Guangxi Dahaiguang Pharmaceutical Co., Ltd.
  • Gansu Lanyao Pharmaceutical Co., Ltd.
  • Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
  • Aimin Pharmaceutical Group Co., Ltd.
  • Weleda
  • Raritan Pharmaceuticals
  • Hyland's Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Belladonna Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Belladonna Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Belladonna Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Belladonna Tablets Market Dynamics
  1. 2.1 Belladonna Tablets Industry Trends
  2. 2.2 Belladonna Tablets Industry Drivers
  3. 2.3 Belladonna Tablets Industry Opportunities and Challenges
  4. 2.4 Belladonna Tablets Industry Restraints
3 Belladonna Tablets Market by Company
  1. 3.1 Global Belladonna Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Belladonna Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Belladonna Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Belladonna Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Belladonna Tablets Company Ranking (2024-2026)
  6. 3.6 Global Belladonna Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Belladonna Tablets Company Product Type and Application
  8. 3.8 Global Belladonna Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Belladonna Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Belladonna Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Belladonna Tablets Market by Type
  1. 4.1 Belladonna Tablets Type Introduction
  2. 4.1.1 Compound Preparations
  3. 4.1.2 Single Preparations
  4. 4.2 Global Belladonna Tablets Sales Volume by Type
  5. 4.2.1 Global Belladonna Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Belladonna Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Belladonna Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Belladonna Tablets Sales Value by Type
  9. 4.3.1 Global Belladonna Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Belladonna Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Belladonna Tablets Sales Value Share by Type (2021-2032)
5 Belladonna Tablets Market by Application
  1. 5.1 Belladonna Tablets Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Belladonna Tablets Sales Volume by Application
  6. 5.2.1 Global Belladonna Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Belladonna Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Belladonna Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Belladonna Tablets Sales Value by Application
  10. 5.3.1 Global Belladonna Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Belladonna Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Belladonna Tablets Sales Value Share by Application (2021-2032)
6 Belladonna Tablets Regional Sales and Value Analysis
  1. 6.1 Global Belladonna Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Belladonna Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Belladonna Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Belladonna Tablets Sales by Region (2027-2032)
  5. 6.3 Global Belladonna Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Belladonna Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Belladonna Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Belladonna Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Belladonna Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Belladonna Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Belladonna Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Belladonna Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Belladonna Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Belladonna Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Belladonna Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Belladonna Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Belladonna Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Belladonna Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Belladonna Tablets Sales Value Share by Country, 2025 VS 2032
7 Belladonna Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Belladonna Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Belladonna Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Belladonna Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Belladonna Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Belladonna Tablets Sales by Country (2027-2032)
  6. 7.4 Global Belladonna Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Belladonna Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Belladonna Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Belladonna Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Belladonna Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Belladonna Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Belladonna Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Belladonna Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Belladonna Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Belladonna Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Belladonna Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Belladonna Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Belladonna Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Belladonna Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Belladonna Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Belladonna Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Belladonna Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Belladonna Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Belladonna Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Belladonna Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Belladonna Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Belladonna Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Belladonna Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Belladonna Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Belladonna Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Belladonna Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Belladonna Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Belladonna Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Belladonna Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Belladonna Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Belladonna Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Belladonna Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Belladonna Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd.
  2. 8.1.1 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Company Information
  3. 8.1.2 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Business Overview
  4. 8.1.3 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Belladonna Tablets Product Portfolio
  6. 8.1.5 Original drug Gang Biopharmaceutical (Shenyang) Co., Ltd. Recent Developments
  7. 8.2 Yangzhou Aidi Pharmaceutical Co., Ltd.
  8. 8.2.1 Yangzhou Aidi Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Yangzhou Aidi Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yangzhou Aidi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  12. 8.2.5 Yangzhou Aidi Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Southwest Pharmaceutical Co., Ltd.
  14. 8.3.1 Southwest Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Southwest Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Southwest Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  18. 8.3.5 Southwest Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Wanbangde Pharmaceutical Group Co., Ltd.
  20. 8.4.1 Wanbangde Pharmaceutical Group Co., Ltd. Company Information
  21. 8.4.2 Wanbangde Pharmaceutical Group Co., Ltd. Business Overview
  22. 8.4.3 Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Wanbangde Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio
  24. 8.4.5 Wanbangde Pharmaceutical Group Co., Ltd. Recent Developments
  25. 8.5 CSPC Ouyi Pharmaceutical Co., Ltd.
  26. 8.5.1 CSPC Ouyi Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 CSPC Ouyi Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CSPC Ouyi Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  30. 8.5.5 CSPC Ouyi Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Shenyang Tonglian Pharmaceutical Co., Ltd.
  32. 8.6.1 Shenyang Tonglian Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Shenyang Tonglian Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shenyang Tonglian Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  36. 8.6.5 Shenyang Tonglian Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd.
  38. 8.7.1 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  42. 8.7.5 Shanghai Yurui Biotechnology (Anyang) Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd.
  44. 8.8.1 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  48. 8.8.5 Shaanxi Sun Simiao High-tech Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd.
  50. 8.9.1 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  54. 8.9.5 Shanxi Zhendong Anxin Biopharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd.
  56. 8.10.1 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Company Information
  57. 8.10.2 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Business Overview
  58. 8.10.3 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Belladonna Tablets Product Portfolio
  60. 8.10.5 Shanxi Linfen Jianmin Pharmaceutical Factory Co., Ltd. Recent Developments
  61. 8.11 Jilin Luwang Pharmaceutical Co., Ltd.
  62. 8.11.1 Jilin Luwang Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Jilin Luwang Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Jilin Luwang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  66. 8.11.5 Jilin Luwang Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Jilin Hengjin Pharmaceutical Co., Ltd.
  68. 8.12.1 Jilin Hengjin Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Jilin Hengjin Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  72. 8.12.5 Jilin Hengjin Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Jilin Daojun Pharmaceutical Co., Ltd.
  74. 8.13.1 Jilin Daojun Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Jilin Daojun Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Jilin Daojun Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  78. 8.13.5 Jilin Daojun Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Henan Baiquan Pharmaceutical Co., Ltd.
  80. 8.14.1 Henan Baiquan Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Henan Baiquan Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Henan Baiquan Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  84. 8.14.5 Henan Baiquan Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Sinopharm Xinjiang Pharmaceutical Co., Ltd.
  86. 8.15.1 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  90. 8.15.5 Sinopharm Xinjiang Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Guangxi Dahaiguang Pharmaceutical Co., Ltd.
  92. 8.16.1 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  96. 8.16.5 Guangxi Dahaiguang Pharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Gansu Lanyao Pharmaceutical Co., Ltd.
  98. 8.17.1 Gansu Lanyao Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Gansu Lanyao Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Gansu Lanyao Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  102. 8.17.5 Gansu Lanyao Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd.
  104. 8.18.1 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Company Information
  105. 8.18.2 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Business Overview
  106. 8.18.3 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Belladonna Tablets Product Portfolio
  108. 8.18.5 Beijing Wanhui Shuanghe Pharmaceutical Co., Ltd. Recent Developments
  109. 8.19 Aimin Pharmaceutical Group Co., Ltd.
  110. 8.19.1 Aimin Pharmaceutical Group Co., Ltd. Company Information
  111. 8.19.2 Aimin Pharmaceutical Group Co., Ltd. Business Overview
  112. 8.19.3 Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Aimin Pharmaceutical Group Co., Ltd. Belladonna Tablets Product Portfolio
  114. 8.19.5 Aimin Pharmaceutical Group Co., Ltd. Recent Developments
  115. 8.20 Weleda
  116. 8.20.1 Weleda Company Information
  117. 8.20.2 Weleda Business Overview
  118. 8.20.3 Weleda Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Weleda Belladonna Tablets Product Portfolio
  120. 8.20.5 Weleda Recent Developments
  121. 8.21 Raritan Pharmaceuticals
  122. 8.21.1 Raritan Pharmaceuticals Company Information
  123. 8.21.2 Raritan Pharmaceuticals Business Overview
  124. 8.21.3 Raritan Pharmaceuticals Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Raritan Pharmaceuticals Belladonna Tablets Product Portfolio
  126. 8.21.5 Raritan Pharmaceuticals Recent Developments
  127. 8.22 Hyland's Inc
  128. 8.22.1 Hyland's Inc Company Information
  129. 8.22.2 Hyland's Inc Business Overview
  130. 8.22.3 Hyland's Inc Belladonna Tablets Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Hyland's Inc Belladonna Tablets Product Portfolio
  132. 8.22.5 Hyland's Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Belladonna Tablets Value Chain Analysis
  2. 9.1.1 Belladonna Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Belladonna Tablets Sales Mode & Process
  6. 9.2 Belladonna Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Belladonna Tablets Distributors
  9. 9.2.3 Belladonna Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst